摘要
目的:观察藤龙补中汤对术后化疗后Ⅲ期大肠癌转移的抑制作用。方法:收集2014年1月-2019年12月上海中医药大学附属龙华医院和复旦大学附属肿瘤医院闵行分院术后化疗后I期大肠癌患者101例,根据实际干预措施分为对照组和治疗组,分别予随访或藤龙补中汤治疗。观察患者肿瘤转移、临床证候、生活质量和免疫细胞变化。结果:对照组和治疗组肿瘤转移率分别为44.19%和20.69%(P<0.05)。藤龙补中汤同时可改善患者临床症状和生活质量,升高T细胞亚群、IL-12和NK细胞(P<0.05)。结论:藤龙补中汤维持治疗可抑制术后化疗后Ⅲ期大肠癌转移,同时可改善患者临床证候和生活质量,调节免疫功能。
Objective:To observed the effects of Tenglong Buzhong Decoction(TBD)on metastasis of stage III colorectal cancer after surgery and chemotherapy.Methods:Patients with stage Ill colorectal cancer after surgery and chemotherapy were naturally divided into control and treatment groups according to the actual interventions,and received clinical follow-up or treated with TBD.The metastasis,clinical symptoms,quality of life and immunocytes in those patients were observed.Results:The metastatic rate in control and treatment group was 44.19%and 20.69%respectively(P<O.05).TBD treatment also alleviated clinical symptoms(describe detailed symptoms),improved quality of life,increased T lymphocyte subsets,IL-12 and NK cells(P<0.05).Conclusion:TBD maintenance treatment inhibits metastasis,palliates clinical symptoms,improves quality of life and regulates immune function in patients with stage III colorectal cancer after surgery and chemotherapy.
作者
宝乐日
卢艳琳
蔡芸芸
沈克平
胡兵
BAO Leri;LU Yanlin;CAI Yunyun;SHEN Keping;HU Bing(Department of Oncology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai,200032,China;Department of Integrated Chinese and Wes tern Medicine,Minhang Branch of Fudan University Cancer Hospital;lnstitute of Traditional Chinese Medicine in Oncology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine)
出处
《中国中西医结合消化杂志》
CAS
2022年第7期505-507,513,共4页
Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金
上海市医学引导类(中、西医)科技支撑项目(No:19401933400)
上海市自然科学基金(No 20ZR1458700)。
关键词
大肠癌
藤龙补中汤
转移
临床证候
生活质量
免疫细胞
colorectal cancer
Tenglong Buzhong Decoction
metastasis
clinical syndrome
quality of life
immunocytes